Copyright
©The Author(s) 2022.
World J Gastroenterol. Feb 14, 2022; 28(6): 635-652
Published online Feb 14, 2022. doi: 10.3748/wjg.v28.i6.635
Published online Feb 14, 2022. doi: 10.3748/wjg.v28.i6.635
Figure 3 Segment plots depicting taxa with significantly differences between high viremia (time point 0) and viral suppression (time point 24) conditions.
Lines connect paired samples and highlight the differences in normalized abundance for the indicated rank. Orange or blue colors highlight decrease or increase, respectively. Numbers in the top-left corner represent counts of increased (orange) and decreased (blue) measurement for paired samples.
- Citation: Russo E, Nannini G, Sterrantino G, Kiros ST, Di Pilato V, Coppi M, Baldi S, Niccolai E, Ricci F, Ramazzotti M, Pallecchi M, Lagi F, Rossolini GM, Bartoloni A, Bartolucci G, Amedei A. Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy. World J Gastroenterol 2022; 28(6): 635-652
- URL: https://www.wjgnet.com/1007-9327/full/v28/i6/635.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i6.635